Additional inhibitory effects of intravenous immunoglobulins in combination with cyclosporine on human T lymphocyte alloproliferative response in vitro

Intravenous immunoglobulins (IvIgG) are often used in patients receiving a basic immunosuppressive therapy with CsA either for prevention of infectious complications or as an additional prophylaxis of graft versus host disease in clinical bone marrow transplantation. As far as we know, the combined...

Ausführliche Beschreibung